TET2 and mature T-cell and NK-cell non-Hodgkin lymphoma: Recent studies that have excluded nPTCL-TFH cases highlight that DNMT3A mutations are rare in PTCL-NOS, while TET2 mutations occur in around 20% of cases [45,112,113].